sars-cov-2 vaccine Injection 25 mcg/0.5 ml
Dossier type
CTD
Dossier status
Ready to file
Country of origin
China
GMP approvals
China
Manufacturer #36697
Established in 2002, this manufacturer employs nearly 4,500 staff and achieved an operating income of RMB 13.2 billion in the first half of 2021. As a CTD dossier owner and manufacturer, it specializes in human vaccines, with products available in 31 provinces across China. The manufacturer operates under strict GMP standards, ensuring high-quality production. With multiple production lines, it maintains its role as a CTD dossier owner and manufacturer, adhering to GMP guidelines.